Effect of Rta protein of Epstein-Barr virus on the cell cycle in HeLa cells

Acta Virologica

Volumn 55, Issue 4, 2011, Pages 311-316

  Guo, Qingwei ^a   Sun, Xiaobai ^b   Yuan, Changjin ^c   Zhou, Huijuan ^c   Li, Yanmei ^c   Jie, Gao ^c   Jiang, Guosheng ^c  

^a QILU CHILDREN S HOSPITAL OF SHANDONG UNIVERSITY   (China)

^b Adicona Clinical Laboratories   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; E2F 1; Epstein Barr virus; HeLa cells; p53; Rb; Rta

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN; RTA PROTEIN; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; VIRUS CELL INTERACTION;

CELL CYCLE; CELL TRANSFORMATION, VIRAL; E2F1 TRANSCRIPTION FACTOR; G1 PHASE; HELA CELLS; HERPESVIRUS 4, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; RETINOBLASTOMA PROTEIN; S PHASE; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 84862939517     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: 10.4149/av_2011_04_311     Document Type: Article

References (28)

1. Adamson AL, Darr D, Holley-Guthrie E, Johnson RA, Mauser A, Swenson J, Kenney S (2000): Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J. Virol. 74, 1224-1233. http://dx.doi.org/10.1128/JVI.74.3.1224-1233.2000
2. Brady G, Macarthur GJ, Farrell PJ (2008): Epstein-Barr virus and Burkitt lymphoma. Postgrad. Med. J. 84, 372-377. http://dx.doi.org/10.1136/jcp.2007.047977
3. Chen Y, Tsai W, Ko Y, Chen J, Lin S (2009): The Epstein-Barr virus replication and transcription activator, Rta/BRLF1, induces cellular senescence in epithelial cells. Cell Cycle 8, 58-65. http://dx.doi.org/10.4161/cc.8.1.7411
4. Cohen JI (2000): Epstein-Barr virus infection. N. Engl. J. Med. 343, 481-492. http://dx.doi.org/10.1056/NEJM200008173430707
5. Chang LK, Chung JY, Hong YR, Ichimura T, Nakao M, Liu ST (2005): Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1. Nucleic Acids Res. 33, 6528-6539. http://dx.doi.org/10.1093/nar/gki956
6. Cayrol C, Flemington E (1996a): G0/G1 growth arrest mediated by a region encompassing the basic leucine zipper (bZIP) domain of the Epstein-Barr virus transactivator Zta. J. Biol. Chem. 271, 31799-31802. http://dx.doi.org/10.1074/jbc.271.50.31799
7. Darr, CD, Mauser A, Kenney S (2001): Epstein-Barr virus immediateearly protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation. J. Virol. 75, 6135-6142. http://dx.doi.org/10.1128/JVI.75.13.6135-6142.2001
8. Dolcetti R (2007): B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders. Autoimmun. Rev. 7, 96-101. http://dx.doi.org/10.1016/j.autrev.2007.02.012
9. Ehmann GL, McLean TI, and Bachenheimer SL (2000). Herpes simplex virus type 1 infection imposes a G1/S block in asynchronously growing cells and prevents G1 entry in quiescent cells. Virology. 267, 335-349. http://dx.doi.org/10.1006/viro.1999.0147
10. Flemington EK (2001): Herpesvirus lytic replication and the cell cycle: arresting new developments. J. Virol. 75, 4475-4481. http://dx.doi.org/10.1128/JVI.75.10.4475-4481.2001
11. Guo Q, Qian L, Guo L, Shi M, Chen C, Lv X, Yu M, Hu M, Jiang G, Guo N (2010): Transactivators Zta and Rta of Epstein-Barr virus promote G0/G1 to S transition in Raji cells: A novel relationship between lytic virus and cell cycle. Mol. Immunol. 47, 1783-1792. http://dx.doi.org/10.1016/j.molimm.2010.02.017
12. Guillermina L, Gerard PZ (2005): Gankyrin: An intriguing name for a novel regulator of p53 and RB. Cancer Cell. 8, 3-4. http://dx.doi.org/10.1016/j.ccr.2005.06.014
13. Hobbs WE, DeLuca NA (1999): Perturbation of cell cycle progressionand cellular gene expression as a function of herpes simplex virus ICP0. J. Virol. 73, 8245-8255
14. Klein G (1994): Epstein-Barr virus strategy in normal and neoplastic B cells. Cell. 77, 791-793. http://dx.doi.org/10.1016/0092-8674(94)90125-2
15. Kudoh A, Fujita M, Kiyono T, Kuzushima K, Sugaya Y, Izuta S, Nishiyama Y, Tsurumi T (2003): Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication. J. Virol. 77, 851-861. http://dx.doi.org/10.1128/JVI.77.2.851-861.2003
16. Liu C, Sista ND, Pagano JS (1996): Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate- early protein is mediated through USF and E2F. J. Virol. 70, 2545-2555.
17. Manet E, Rigolet A, Gruffat H, Giot JF, Sergeant A (2009): Domains of the Epstein-Barr virus (EBV) transcription factor R required for dimerization, DNA binding and activation. Nucleic Acids Res. 19, 2661-2667. http://dx.doi.org/10.1093/nar/19.10.2661
18. Mauser A, Holley-Guthrie E, Simpson D, Kaufmann W, Kenney S (2002a): The Epstein-Barr virus immediate-early protein BZLF1 induces both a G(2) and a mitotic block. J. Virol. 76, 10030-10037. http://dx.doi.org/10.1128/JVI.76.19.10030-10037.2002
19. O'Nions J, Allday MJ (2004): Deregulation of the cell cycle by the Epstein-Barr virus. Adv. Cancer Res. 92, 119-186.
20. Packham G, Brimmel M, Cook D, Sinclair AJ, Farrell PJ (1993): Strain variation in Epstein-Barr virus immediate-early genes. Virology 192, 541-550. http://dx.doi.org/10.1006/viro.1993.1070
21. Phillips AC, Ernst MK, Bates S, Rice NR, Vousden KH (1999): E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol. Cell 4, 771-781. http://dx.doi.org/10.1016/S1097-2765(00)80387-1
22. Ragoczy T, Miller G (2001): Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites. J. Virol. 75, 5240-5251. http://dx.doi.org/10.1128/JVI.75.11.5240-5251.2001
23. Swanton C, Jones N (2001): Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products. Int. Exp. Pathol. 82, 3-13. http://dx.doi.org/10.1046/j.1365-2613.2001.00165.x
24. Staudt MR, Dittmer, DP (2007): The Rta/Orf50 transactivator proteins of the gamma-herpesviridae. Curr. Top. Microbiol. Immunol. 312, 71-100. http://dx.doi.org/10.1007/978-3-540-34344-8_3
25. Song B, Liu JJ, Yeh KC, Knipe DM (2000): Herpes simplex virus infection blocks events in the G1 phase of the cell cycle. Virology 267, 326-334. http://dx.doi.org/10.1006/viro.1999.0146
26. Sinclair JJ, Baillie L, Bryant, Caswell R (2000): Human cytomegalovirus mediates cell cycle progression through G1 into early S phase interminally differentiated cells. J. Gen. Virol. 81, 1553-1565.
27. Young LS, Murray PG (2003): Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22, 5108-5121. http://dx.doi.org/10.1038/sj.onc.1206556
28. Zacny VJ, Wilson, Pagano JS (1998): The Epstein-Barr virus immediate-early gene product, BRLF1, interacts with the nretinoblastoma protein during the viral lytic cycle. J. Virol. 72, 8043-8051.